Candel Therapeutics Inc
NASDAQ:CADL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Candel Therapeutics Inc
NASDAQ:CADL
|
US |
|
S
|
Sinopharm Group Co Ltd
F:X2S
|
CN |
|
Re/Max Holdings Inc
NYSE:RMAX
|
US |
|
B
|
Bank Handlowy w Warszawie SA
XMUN:6HW
|
PL |
|
Wolters Kluwer NV
F:WOS
|
NL |
|
ANSYS Inc
NASDAQ:ANSS
|
US |
|
Crane Co
F:T12
|
US |
|
M
|
Mesoblast Ltd
SWB:LWB
|
AU |
|
Logan Energy Corp
F:R76
|
CA |
Wall St Price Targets
CADL Price Targets Summary
Candel Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
CADL is 21.42 USD with a low forecast of 12.12 USD and a high forecast of 30.45 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CADL's stock price target?
Price Target
21.42
USD
According to Wall Street analysts, the average 1-year price target for
CADL is 21.42 USD with a low forecast of 12.12 USD and a high forecast of 30.45 USD.